Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Setmelanotide

Setmelanotide for the Treatment of Leptin Receptor (LEPR) Deficiency Obesity

Rhythm · Phase 3 · Completed · Enrollment 15

NCT03287960

EudraCT 2017-002005-36

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

X axis: threshold category. Y axis: participants reaching threshold, %.

≥5%
45.5
≥10%
≥15%
≥20%
Show as table
Arm≥5%≥10%≥15%≥20%
Setmelanotiden/r45.5%n/rn/r

Not shown

Every selected arm is drawn.